Inactivation of NF-κB2 (p52) restrains hepatic glucagon response via preserving PDE4B induction.
Ontology highlight
ABSTRACT: Glucagon promotes hepatic gluconeogenesis and maintains whole-body glucose levels during fasting. The regulatory factors that are involved in fasting glucagon response are not well understood. Here we report a role of p52, a key activator of the noncanonical nuclear factor-kappaB signaling, in hepatic glucagon response. We show that p52 is activated in livers of HFD-fed and glucagon-challenged mice. Knockdown of p52 lowers glucagon-stimulated hyperglycemia, while p52 overexpression augments glucagon response. Mechanistically, p52 binds to phosphodiesterase 4B promoter to inhibit its transcription and promotes cAMP accumulation, thus augmenting the glucagon response through cAMP/PKA signaling. The anti-diabetic drug metformin and ginsenoside Rb1 lower blood glucose at least in part by inhib
SUBMITTER: Zhang WS
PROVIDER: S-EPMC6754499 | biostudies-literature | 2019 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA